🇳🇱 Netherlands insider buying in September 2026
Directors and managers of Netherlands listed companies made 75 open-market share purchases in September 2026, worth €1.5M in total across 16 companies and 73 insiders. The largest was Leysen T. at DSM-Firmenich AG, for €470k. Data from AFM filings under MAR Article 19; transactions above €100m are excluded as likely holding-threshold filings rather than trades.
Largest insider buys
| Date | Company | Insider | Value |
|---|---|---|---|
| 2026-09-30 | DSM-Firmenich AG | Leysen T. | €470k |
| 2026-09-04 | argenx SE | Borgions F. | €309k |
| 2026-09-30 | DSM-Firmenich AG | Firmenich P. | €144k |
| 2026-09-30 | DSM-Firmenich AG | Pometta A. | €117k |
| 2026-09-24 | Shell Plc | Gorman S. | €102k |
| 2026-09-24 | Shell Plc | Sawan W. | €93k |
| 2026-09-01 | Tetragon Financial Group Limited | Griffith R.E. | €75k |
| 2026-09-24 | Shell Plc | Smith A. | €27k |
| 2026-09-23 | Unilever Plc | Nair P. | €23k |
| 2026-09-24 | Shell Plc | Haan, de M. | €18k |
| 2026-09-24 | Shell Plc | Cremers C. | €17k |
| 2026-09-18 | NEPI Rockcastle N.V. | Florescu A. | €16k |
| 2026-09-23 | Unilever Plc | Nayager M. | €14k |
| 2026-09-15 | CTP N.V. | Otte M. | €10k |
| 2026-09-25 | CTP N.V. | Otte M. | €10k |
| 2026-09-23 | Unilever Plc | Ecclissato R. | €9k |
| 2026-09-24 | Shell Plc | Bounds P. | €9k |
| 2026-09-23 | Shell Plc | Bounds P. | €8k |
| 2026-09-23 | Unilever Plc | Campanella E. | €7k |
| 2026-09-23 | Unilever Plc | Slater R. | €7k |
| 2026-09-23 | Unilever Plc | Uijen W. | €7k |
| 2026-09-24 | Shell Plc | Solway R. | €5k |
| 2026-09-23 | Unilever Plc | Schipper H. | €5k |
| 2026-09-23 | Shell Plc | Bounds B. | €5k |
| 2026-09-25 | ASR Nederland N.V. | Berg, van den W. | €3k |
Most-bought companies
- DSM-Firmenich AG3 buys · €731k
- argenx SE2 buys · €309k
- Shell Plc13 buys · €287k
- Unilever Plc9 buys · €77k
- Tetragon Financial Group Limited1 buy · €75k
- CTP N.V.2 buys · €21k
- NEPI Rockcastle N.V.1 buy · €16k
- ASR Nederland N.V.3 buys · €9k
- Coca-Cola Europacific Partners plc5 buys · €2k
- TME Pharma N.V.4 buys · €0